Cannabidiol shows preclinical promise for anxiety, depression and cognition
A new Molecular Psychiatry meta-analysis suggests CBD may improve emotional behavior and cognition in animal models, but researchers…
New drug candidate reduces toxic protein clumps of Huntington’s disease
An experimental drug has been shown to alleviate symptoms of Huntington’s disease and extend lifespan in mouse models.…
Nasal viruses may drive allergic rhinitis, and ribavirin shows early promise as a targeted spray treatment
A new study suggests that clearing symptom-driving nasal viruses could calm allergic inflammation and open a fresh treatment…
Engineered CAR-T cells offer potential rheumatoid arthritis cure
For the 18 million people living with rheumatoid arthritis, disease management currently means a lifetime of injections-a reality…
Gene therapy successfully treats deadly childhood liver disease in mice
A new gene therapy has been used to successfully treat a deadly childhood liver disease using mice that…
NAFDAC warns Nigerians as US recalls children’s ibuprofen over contamination concerns
The National Agency for Food and Drug Administration and Control (NAFDAC) has alerted healthcare providers, importers, distributors and…
Parkinson’s drug may ease anhedonia in treatment-resistant depression
For many people who suffer from depression, the condition is not just about feeling down, but also about…
Apitegromab helps tirzepatide users lose fat while preserving lean mass
A phase 2 trial suggests that blocking myostatin activation may help people taking tirzepatide retain more lean body…
Enhancing drug development with human muscle platforms
In this interview, News-Medical LifeSciences speaks with Professor Mark Lewis, Co-Founder and CEO of Myomaker Bio, about the development…
Novel PRRT approach shows promise in advanced neuroendocrine tumors
A new type of peptide receptor radionuclide therapy (PRRT) appears to be safe in metastatic neuroendocrine tumor patients…
WHO prioritizes candidate vaccines and therapeutics for Bundibugyo virus
In response to the current outbreak of Ebola disease caused by Bundibugyo virus occurring in the Democratic Republic…
Scientists rethink GLP-1 delivery to improve dosing, tolerability, and adherence
From microneedles to nanocarriers, researchers are rethinking how GLP-1 medicines could become longer-lasting, easier to tolerate, and more…